MAMMÔ 2026: Global Breast Cancer Virtual Congress
Phase 3 TITAN Trial: CRPC Progression Patterns After Apalutamide in mCSPC
GCOS 2026 Second Half of the Day 1: From Amyloidosis to the Ten Laws of Cardio-Oncology
BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals
Jesper Fisker Named Candidate for UICC Board of Directors 2026–2028
Enrique Grande: Celebrating Two Days of High-Level Oncology and Collaboration
The Tumor Microenvironment and Immune Escape: Mechanisms and Therapeutic Implications
NEO Trial: Tissue-Free ctDNA in Early-Stage Rectal Cancer
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
